BELTSVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that clinical trial investigator Eric S. Christenson, M.D., Assistant Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer… Read More..
The Collaboration will Include SKYX’s Advanced and Smart Products to Both Professional and Retail Markets The Collaboration Agreement Provides SKYX Substantial Backing in Several Areas Including Financial, Mass Production Manufacturing Capabilities, and Distribution to Global Markets MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX… Read More..
BioStem CEO, Jason Matuszewski, will present on Wednesday, May 1, 2024 at 11.30 am PST POMPANO BEACH, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today… Read More..